Literature for EF6265 (M14.009 inhibitor)

(Topics flags: S Structure, I Inhibitor. To select only the references relevant to a single topic, click the link above. See explanation.)

2013
1. Yoshimoto,N., Itoh,T., Inaba,Y., Ishii,H. and Yamamoto,K.
   Structural basis for inhibition of carboxypeptidase B by selenium-containing inhibitor: selenium coordinates to zinc in enzyme
   J Med Chem56, 7527-7535. PubMed  Europe PubMed DOI  S  I
2009
2. Muto,Y., Suzuki,K., Iida,H., Sakakibara,S., Kato,E., Itoh,F., Kakui,N. and Ishii,H.
   EF6265, a novel inhibitor of activated thrombin-activatable fibrinolysis inhibitor, protects against sepsis-induced organ dysfunction in rats
   Crit Care Med37, 1744-1749. PubMed  Europe PubMed DOI  I
2007
3. Muto,Y., Suzuki,K., Iida,H. and Ishii,H.
   EF6265, a novel plasma carboxypeptidase B inhibitor, protects against renal dysfunction in rat thrombotic glomerulonephritis through enhancing fibrinolysis
   Nephron Exp Nephrol106, e113-e121. PubMed  Europe PubMed DOI  I